Abstract: Systems, methods, and articles of manufacture to manage tracks and/or other multimedia items are disclosed. An example method includes displaying on an interface of a computing device, a plurality of tracks in a sequential order. The example method receiving, via the interface, an input to play a particular track from the plurality of tracks, wherein the particular track is at a particular position in the sequential order. The example method displaying on the interface, a queue comprising at least a subset of the plurality of tracks to be played after playback of the particular track, wherein each track in the subset of the plurality of tracks is at a different position in the sequential order than the particular position of the particular track.

Abstract: Techniques for managing a playlist in a multimedia system are disclosed. According to one aspect of the techniques, the playlist is structured to be able to include as many items as desired. To facilitate the manageability of such playlist, the playlist is built with a plurality of items. Each of the items is associated with metadata that includes information related to, for example, artist, album, genre, composer, and track number. The metadata for each item may be parsed, updated or logically operated upon to facilitate the management of the playlist. In another embodiment, each of the items is either a single item or a group item. A single item contains metadata of a corresponding source. A group item contains metadata of accessing other constituent items, which again may be single items or group items. As a result, the playlist can accommodate as many items as desired in a limited memory space without compromising the manageability of the playlist.

Abstract: Techniques for managing a playlist in a multimedia system are disclosed. According to one aspect of the techniques, the playlist is structured to be able to include as many items as desired. To facilitate the manageability of such playlist, the playlist is built with a plurality of items. Each of the items is associated with metadata that includes information related to, for example, artist, album, genre, composer, and track number. The metadata for each item may be parsed, updated or logically operated upon to facilitate the management of the playlist. In another embodiment, each of the items is either a single item or a group item. A single item contains metadata of a corresponding source. A group item contains metadata of accessing other constituent items, which again may be single items or group items. As a result, the playlist can accommodate as many items as desired in a limited memory space without compromising the manageability of the playlist.

Abstract: Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: Techniques for managing a playlist in a multimedia system are disclosed. According to one aspect of the techniques, the playlist is structured to be able to include as many items as desired. To facilitate the manageability of such playlist, the playlist is built with a plurality of items. Each of the items is associated with metadata that includes information related to, for example, artist, album, genre, composer, and track number. The metadata for each item may be parsed, updated or logically operated upon to facilitate the management of the playlist. In another embodiment, each of the items is either a single item or a group item. A single item contains metadata of a corresponding source. A group item contains metadata of accessing other constituent items, which again may be single items or group items. As a result, the playlist can accommodate as many items as desired in a limited memory space without compromising the manageability of the playlist.

Abstract: Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: Systems, methods, and articles of manufacture to manage tracks and/or other multimedia items are disclosed. An example method includes displaying on an interface of a computing device, a plurality of tracks in a sequential order. The example method receiving, via the interface, an input to play a particular track from the plurality of tracks, wherein the particular track is at a particular position in the sequential order. The example method displaying on the interface, a queue comprising at least a subset of the plurality of tracks to be played after playback of the particular track, wherein each track in the subset of the plurality of tracks is at a different position in the sequential order than the particular position of the particular track.

Abstract: A smartphone is adapted, through software modifications, to provide multiple operating domains or domains that provide differing levels of security and reliability. Each operating domain is isolated from the others. Detection of unauthorized modification is provided in some embodiments. Cross domain activity notification is provided in some embodiments.

Abstract: Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: Disclosed are compounds of formula (I): or a pharmaceutically acceptable salt, derivative, solvate, isomer, tautomer, N-oxide, ester, prodrug, isotope or protected form thereof, which are of use as OGA inhibitors, for example in the treatment of various conditions and diseases, including neurodegenerative disorders.

Abstract: There are disclosed compound of Formula (1): A1, A2, A3 and A4 which may be the same or different, represent N or CR1, X is a divalent group selected from O, S(O)n, C?W, NR4, NC(?O)R5 and CR6R7, W is O, S, NR20, Y is N or CR8, one of R4, R5, R6, R8, R9 and NR20 represents -L-R3, in which L is a single bond or a linker group, additionally, R1, R3-R9, which may be the same or different, independently represent hydrogen or a substituent and R20 represents hydrogen, hydroxyl, alkyl optionally substituted by aryl, alkoxy optionally substituted by aryl, aryl, CN, optionally substituted alkoxy, optionally substituted aryloxy, optionally substitute alkanoyl, optionally substituted aroyl, NO2, NR30R31, in which R30 and R31, which may be the same or different, represent hydrogen, optionally substituted alkyl or optionally substituted aryl; additionally, one of R30 and R31 may represent optionally substituted alkanoyl or optionally substituted aroyl, n represents an integer from 0 to 2, in addition, when an adjacent pai

Abstract: Combinations comprising (or consisting essentially of) one or more compounds of formula (1) with one or more ancillary agents, to processes for preparing the combinations, and to various therapeutic uses of the combinations. Also provided are pharmaceutical compositions containing the combinations as well as a method of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia using the combinations.

Abstract: A method for a mobile communication device to indicate activity associated with an operating domain includes establishing a plurality of operating domains for the mobile communication device each operating as an independent virtual machine. The method also includes providing a trusted indicator at the mobile communication device for indicating activity associated with a high-side domain. The method also includes providing an input on the mobile communication device for switching from a low-side domain to the high-side domain. The method also includes providing a trusted element for the mobile communication device that is independent of either the high-side domain or the low-side domain. The trusted element may be configured to receive a signal from the input for switching from the low-side domain to the high-side domain and to perform user authentication for switching from the low-side domain to the high-side domain.

Abstract: Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Abstract: A smartphone is adapted, through software modifications, to provide multiple operating domains or domains that provide differing levels of security and reliability. Each operating domain is isolated from the others. Detection of unauthorized modification is provided in some embodiments. Cross domain activity notification is provided in some embodiments.

Abstract: Techniques for managing a playlist in a multimedia system are disclosed. According to one aspect of the techniques, the playlist is structured to be able to include as many items as desired. To facilitate the manageability of such playlist, the playlist is built with a plurality of items. Each of the items is associated with metadata that includes information related to, for example, artist, album, genre, composer, and track number. The metadata for each item may be parsed, updated or logically operated upon to facilitate the management of the playlist. In another embodiment, each of the items is either a single item or a group item. A single item contains metadata of a corresponding source. A group item contains metadata of accessing other constituent items, which again may be single items or group items. As a result, the playlist can accommodate as many items as desired in a limited memory space without compromising the manageability of the playlist.

Abstract: There are disclosed compound of Formula (1): A1, A2, A3 and A4 which may be the same or different, represent N or CR1, X is a divalent group selected from O, S(O)n, C?W, NR4, NC(?O)R5 and CR6R7, W is O, S, NR20, Y is N or CR8, one of R4, R5, R6, R8, R9 and NR20 represents -L-R3, in which L is a single bond or a linker group, additionally, R1, R3-R9, which may be the same or different, independently represent hydrogen or a substituent and R20 represents hydrogen, hydroxyl, alkyl optionally substituted by aryl, alkoxy optionally substituted by aryl, aryl, CN, optionally substituted alkoxy, optionally substituted aryloxy, optionally substitute alkanoyl, optionally substituted aroyl, NO2, NR30R31, in which R30 and R31, which may be the same or different, represent hydrogen, optionally substituted alkyl or optionally substituted aryl; additionally, one of R30 and R31 may represent optionally substituted alkanoyl or optionally substituted aroyl, n represents an integer from 0 to 2, in addition, when an adjacent pai

Abstract: Combinations comprising (or consisting essentially of) one or more compounds of formula (1) with one or more ancillary agents, to processes for preparing the combinations, and to various therapeutic uses of the combinations. Also provided are pharmaceutical compositions containing the combinations as well as a method of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia using the combinations.